million american adult live depression many one quarter gain little benefit available treatment whether drug talk therapy represent perhaps greatest unmet need psychiatry tuesday food drug administration approved prescription treatment intended help fast acting drug derived old widely used anesthetic ketamine 
move herald shift prozac era antidepressant drug newly approved treatment called esketamine nasal spray developed janssen pharmaceutical inc branch johnson johnson marketed name spravato contains active portion ketamine molecule whose antidepressant property well understood yet 
thank goodness something different mechanism action previous antidepressant said dr erick turner former reviewer associate professor psychiatry oregon health science university skeptical hype world like lucy holding football charlie brown time get hope football get pulled away 
generic anesthetic already increasingly available depression hundred clinic around country provide course intravenous treatment study suggest help treatment resistant people often cause body hallucinogenic sensation administered popular club drug special 
cost treatment typically pocket generic anesthetic approved depression contrast esketamine likely would covered many insurance plan side effect though similar generic ketamine thought le dramatic 
recommended course newly approved drug twice week four week booster needed along one commonly used oral antidepressant approval requires dos taken doctor office clinic patient monitored least two hour experience entered registry patient drive day treatment 
esketamine like ketamine potential abuse drug induce psychotic episode people high risk safety monitoring require doctor find space treated patient could present logistical challenge psychiatrist said 
cost one month course treatment said janssen expert said give company foothold billion global antidepressant market drug generic 
like science time page facebook sign science time newsletter 
approval esketamine mark new approach treating serious mood problem expert said prozac similar drug enhance activity brain messenger serotonin mildly effective take week month effect felt many patient provide little relief depression contrast ketamine based compound several others developed work within hour day effective people considered treatment resistant meaning benefited antidepressant 
exciting time sure said dr todd gould associate professor psychiatry university maryland school medicine drug work rapidly treat severe illness dr gould involved janssen study identified metabolite ketamine breakdown product could developed another drug 
expert long experience treating depression encouraged news also chary effectiveness previous class antidepressant prozac paxil vastly exaggerated came market result esketamine trial paid carried janssen mixed 
trial submitted patient started new antidepressant drug given course esketamine treatment placebo one monthlong study esketamine performed better statistically placebo reducing score standard point depression scale point compared point placebo two others trial drug statistically outperform placebo treatment historically required drug succeed two short term trial approved agency loosened criterion esketamine opting instead study relapse people well drug 
trial janssen reported one quarter subject relapsed compared percent subject received placebo spray subject given diagnosis treatment resistant depression previously failed multiple course drug treatment 
nothing new year said steven hollon professor psychiatry behavior science vanderbilt university drug effective way get rapid response people treatment resistant use safely could godsend 
one question need answered well esketamine performs comparison intravenous ketamine 
theresa adjunct professor english new york asked last name omitted protect privacy lived much life deep depression tried course generic ketamine last summer local clinic typically entail half dozen infusion given couple week apiece follow booster treatment needed 
remember floating really high said tripping sound texture shape much part 
first infusion provided relief said third fourth noticed satisfying shift underlying mood hard thing describe still anxious felt somehow solid like something gelled within husband noticed 
dr glen brook founder medical director ny ketamine infusion clinic downtown manhattan said treated people age intravenous ketamine generic anesthetic client received variety diagnosis including post traumatic stress anxiety obsessive compulsive disorder well depression 
common medication failed dr brook anesthesiologist said hopeless think nothing else worked said experience infusion quickly reduced symptom teenager young adult seemed le effective people 
data janssen presented likewise suggested esketamine le effective people aged older barely better placebo treatment 
ketamine developed five decade ago safer alternative anesthetic phencyclidine pcp used worldwide operating room battlefield pediatric clinic world health organization listed ketamine one essential medicine since 
interest turned drug potential combat depression government scientist named phil skolnick argued targeting glutamate pathway primary excitatory neuroactivating brain process could produce antidepressant effect team researcher yale university connecticut mental health center led dr robert berman reported dos ketamine provided quick relief seven people depression 
field took team national institute mental health led dr carlos zarate jr reported treatment resistant people received drug intravenously reported despair lifted within hour 
seems remarkable drug also seems help domain depression like anxiety suicidal thinking anhedonia inability feel pleasure said dr zarate chief experimental therapeutic pathophysiology branch seems broad effect many area mood 
apparent ability ketamine blunt suicidal thinking particularly compelling janssen pursuing indication esketamine jail psychiatry ward suicide acute risk people crisis fast acting drug could save many life doctor said 
one know whether esketamine ketamine based compound studied effective generic anesthetic matter whether body hallucinatory side effect fact integral antidepressant property 
need head head study dr zarate said yet 
